The U.S. Small Business Administration and the New Hampshire Bankers Association announced its 2017 New Hampshire Small Business Award winners Friday, recognizing outstanding small business owners throughout the state. Jake Reder, Ph.D., co-founder and CEO of Celdara Medical LLC of Lebanon, was selected as SBA’s New Hampshire Small Business Person […]
Celdara Medical, LLC (Celdara) today announced that it has been recognized as the fastest growing company in the State of New Hampshire by Business NH Magazine. This award is based on 3-year average revenue growth, where Celdara delivered an average 198% growth rate, leading all companies in all categories. This […]
Celdara Medical, LLC today announced the opening of a new office in the Washington D.C. Metropolitan Area. Celdara Medical currently has offices in Greater Boston and New York City, and affiliates in Seattle (Virtici) and Indianapolis (MBV). “This expansion is a direct reflection of the importance of the D.C. region […]
Celdara Medical, LLC announced receipt of a clinical milestone payment from partner Celyad, SA (NASDAQ: CYAD). This milestone payment is related to the advancement of the OnCyte product candidate CM-CS1, currently in Phase I clinical development (NCT02203825) at the Dana Farber Cancer Institute. OnCyte was acquired by Celyad from Celdara […]
Today Celdara Medical, Virtici, and MBV announced their formation of the first collaborative nationwide network for the development of early stage biotechnologies. The goals are simple: to improve human health by identifying the highest potential innovations in medicine, and developing them into the clinic. The companies share a highly collaborative […]
Celdara Medical, LLC and Pulmatrix, Inc. (NASDAQ: PULM) today announced that the National Heart Lung and Blood Institute of the National Institutes of Health has awarded a three-year, $1.7 million Fast Track Small Business Innovation Research grant to fund the companies’ development of an inhaled biologic to treat idiopathic pulmonary […]
Celdara Medical, LLC announced today that it has elected Lita Nelsen to its Board of Directors, and appointed her as a Member of the Company. “Lita is trailblazer and an innovator, and sets the bar for what the interface between academia and industry can be,” said Jake Reder, Ph.D., cofounder […]
Celdara Medical, LLC announced today that it has received a $288k SBIR Phase I award from the National Institutes of Health’s National Cancer Institute (NCI). This award will support proof-of-concept for combination immunotherapies for the treatment of melanoma. “Immunotherapies have clearly demonstrated their worth in the clinic, but none is […]
Celdara Medical, LLC announced today that it has received national recognition from the Small Business Administration (SBA) in the form of a Tibbetts Award. The award recognizes unique contributions to the Small Business Innovation Research (SBIR) Program. John Williams, the Director of Innovation and Technology in the Office of Investment […]
Cardio3 BioSciences (C3BS) (Euronext Brussels and Paris: CARD), a leader in the discovery and development of cell therapies, today announced the acquisition of OnCyte, LLC a division of Celdara Medical, and its portfolio of immuno-oncology CAR T cell product candidates. The acquisition marks Cardio3 Biosciences’ entry into the rapidly growing […]